Page Menu

Sumner Burstein credited for success of local pharmaceutical company

Date Posted: Thursday, November 03, 2016

Corbus Pharmaceuticals has announced that it has received a 5 million dollar award from the Cystic Fibrosis Foundation to start phase 2 clinical trials of their oral anti-inflammatory drug, Resunab. Sumner Burstein, professor emeritus in BMP, discovered Resunab here at UMass Medical School. Read more in the article featured in Boston Business Journal.

▴ Back To Top
▲ Back To Top
Additional Resources
click to open search panel